regulatory

News

Medicine bottle pouring red liquid medicine into teaspoon

FDA bans red dye used in medicines over cancer risk

The FDA has banned the use of a red dye used in oral medicines, foods and dietary supplements, more than 30 years after it was linked to cancer.

News

Yellow water balloon and hand with needle

J&J files intravesical bladder cancer drug TAR-200 in US

Johnson & Johnson has started a marketing application in the US for TAR-200 as a treatment for non-muscle-invasive bladder cancer (NMIBC).

News

FDA sets August date for subcutaneous Leqembi decision

FDA has started its review of an autoinjector version of Eisai and Biogen's Alzheimer's drug Leqembi that could allow patients to be dosed at home.

R&D

The intricacies of effectively transitioning active clinical...

European Union lawmakers designed EU Clinical Trial Regulation 536/2014 to heighten interest within the healthcare industry for planning and conducting clinical trials in the

News

Grifols files drug for rare bleeding disorder in the US

Grifols has filed for FDA approval of its new drug for bleeding disorder acquired fibrinogen deficiency (AFD), aiming for a first-in-class US launch.

Market Access

Graphic of an upward trajectory arrow with woman and telescope atop

The biopharma outlook for 2025: Opportunities and challenges

With the Federal Reserve poised to implement interest rate cuts (albeit fewer than earlier forecasts assumed) and FTC leadership turnover anticipated, there may be broader shifts in how cap

FDA bans red dye used in medicines over cancer risk

J&J files intravesical bladder cancer drug TAR-200 in US

FDA sets August date for subcutaneous Leqembi decision

The intricacies of effectively transitioning active clinical...

Grifols files drug for rare bleeding disorder in the US

The biopharma outlook for 2025: Opportunities and challenges

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

regulatory

Editor's Picks